NYSE:SHC - Sotera Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $32.15
  • Forecasted Upside: 37.45 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$23.39
▼ -0.54 (-2.26%)
1 month | 3 months | 12 months
Get New Sotera Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SHC

Average Price Target: $32.15
▲ +37.45% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Sotera Health in the last 3 months. The average price target is $32.15, with a high forecast of $35.00 and a low forecast of $29.00. The average price target represents a 37.45% upside from the last price of $23.39.

Buy

The current consensus among 10 contributing investment analysts is to buy stock in Sotera Health.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/28/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/23/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/25/2021Credit Suisse GroupReiterated RatingBuy$31.00Low
5/14/2021BarclaysLower Price TargetOverweight$35.00 ➝ $29.00High
3/10/2021KeyCorpBoost Price TargetOverweight$31.00 ➝ $33.00High
3/2/2021BarclaysInitiated CoverageOverweight$35.00Low
1/13/2021Robert W. BairdInitiated CoverageOutperform$31.00Medium
12/15/2020Smith Barney CitigroupInitiated CoverageBuy$32.00High
12/15/2020KeyCorpInitiated CoverageOverweight$31.00Low
12/15/2020JPMorgan Chase & Co.Initiated CoverageOverweight$35.00High
12/15/2020Jefferies Financial GroupInitiated CoverageBuy$33.50High
12/15/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated CoverageBuy$32.00High
12/15/2020Royal Bank of CanadaInitiated CoverageOutperform$31.00High
12/15/2020Credit Suisse GroupInitiated CoverageOutperform$31.00Low
12/15/2020The Goldman Sachs GroupInitiated CoverageBuy$34.00Low
(Data available from 6/20/2016 forward)
Sotera Health logo
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Read More

Today's Range

Now: $23.39
Low: $23.32
High: $23.84

50 Day Range

MA: $24.53
Low: $21.60
High: $26.29

52 Week Range

Now: $23.39
Low: $21.21
High: $30.38

Volume

1,520,425 shs

Average Volume

1,246,703 shs

Market Capitalization

$6.62 billion

P/E Ratio

61.55

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Sotera Health?

The following Wall Street sell-side analysts have issued research reports on Sotera Health in the last twelve months: Barclays PLC, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Robert W. Baird, Royal Bank of Canada, Smith Barney Citigroup, The Goldman Sachs Group, Inc., and Zacks Investment Research.
View the latest analyst ratings for SHC.

What is the current price target for Sotera Health?

10 Wall Street analysts have set twelve-month price targets for Sotera Health in the last year. Their average twelve-month price target is $32.15, suggesting a possible upside of 37.5%. JPMorgan Chase & Co. has the highest price target set, predicting SHC will reach $35.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $29.00 for Sotera Health in the next year.
View the latest price targets for SHC.

What is the current consensus analyst rating for Sotera Health?

Sotera Health currently has 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SHC will outperform the market and that investors should add to their positions of Sotera Health.
View the latest ratings for SHC.

What other companies compete with Sotera Health?

How do I contact Sotera Health's investor relations team?

Sotera Health's physical mailing address is 9100 SOUTH HILLS BLVD SUITE 300, BROADVIEW HEIGHTS OH, 44147. The company's listed phone number is 440-262-1410 and its investor relations email address is [email protected] The official website for Sotera Health is www.soterahealth.com.